Ecstasy (MDMA) toxicity: Difference between revisions

Line 60: Line 60:


==Sources==
==Sources==
Harwood-Nuss, Rosens, EMedicine
<references />


[[Category:Tox]]
[[Category:Tox]]

Revision as of 19:04, 9 December 2014

MDMA

Background

  • 3,4-methylenedioxymethamphetamine (MDMA)
  • other names: E, X, XTC, Adam, Stacy
  • causes catecholamine release, serotonin release, and inhibits serotonin re-uptake
  • "rave" parties
  • 1-2 mg/kg effective dose; onset 30min-1 hour, peak 4 hours, lasts 8-24 hours
  • typical tablets contain 50-100mg of ecstatsy (although other substances possible)

Clinical Features

Workup

Hallucination workup

  • Urine pregnancy
  • CBC, Metabolic panel, LFTs, coags, APAP level, ASA level
  • Total CK level
  • ECG
  • UA
  • Tox screen, blood alcohol
  • Serum osmoles, urine Na (if Hyponatremia present)
  • Head CT as indicated
  • LP to rule out Meningitis if infectious symptoms and based on history and physical
  • Urine tox fails to detect unless large doeses
    • Positive test for amphetamines if only large doses
    • Confirmation must use specialized lab tests (gas chromatography)
  • Chest pain w/u if CP present
  • Blood and urine cultures if signs of infection
  • Consider LP to exclude meningitis

Treatment

  • ABCs
  • IV, O2, monitor
  • Agitation
    • benzos
    • haldol
  • Seizure:
    • benzos
    • phenobarbital (20mg/kg), propofol
    • avoid dilantin
    • manage airway as indicated
  • Seizure AND Hyponatremia
    • hypertonic saline (3% NS) 2-3 ml/kg IV
      • bolus until sz stops (need to raise serum Na by 3-5 meq/L)
  • Hyponatremia:
    • fluids restrict most pt's, unless hypovolemic. correct Na slowly: 0.5 meq/h; 10-12 meq/24h
  • Hyperthermia:
    • ice packs, cold IVF, consider dantrolene 1mg/kg IV
  • Rhabdo
    • foley, IVF

Disposition

  • Admit pt's with complications of ingestion
  • Discharge those who are asymptomatic and no life threatening complication

Sources

  1. Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. J Psychopharmacol. 2012;26(3):408-18
  2. Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F. Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol. 2010;11(5):476-95